Literature DB >> 23400361

A comparison between radiometric and fluorimetric methods for measuring SSAO activity.

Alejandro Gella1, Montse Solé, Irene Bolea, Mariacarla Ventriglia, Mariacristina Siotto, Nuria Durany, Rosanna Squitti, Mercedes Unzeta.   

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) metabolizes the oxidative deamination of primary aromatic and aliphatic amines. The final cytotoxic products of its catalysis contribute to diseases involving vascular degeneration. The increasing interest in measuring SSAO activity has led to the development of several different methods. Herein, we compare SSAO activity results obtained with radiometric and fluorimetric methods in 49 plasma samples. Although not interchangeable, a significant correlation was obtained between methods. Considering these limitations, the fluorimetric method might replace the radioisotopic one.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400361     DOI: 10.1007/s00702-013-0987-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

Authors:  Mar Hernandez-Guillamon; Lidia Garcia-Bonilla; Montse Solé; Victoria Sosti; Mireia Parés; Mireia Campos; Arantxa Ortega-Aznar; Carmen Domínguez; Marta Rubiera; Marc Ribó; Manolo Quintana; Carlos A Molina; José Alvarez-Sabín; Anna Rosell; Mercedes Unzeta; Joan Montaner
Journal:  Stroke       Date:  2010-06-10       Impact factor: 7.914

2.  RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA.

Authors:  S OTSUKA; Y KOBAYASHI
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.

Authors:  Mar Hernandez-Guillamon; Montse Solé; Pilar Delgado; Lidia García-Bonilla; Dolors Giralt; Cristina Boada; Anna Penalba; Sandra García; Alan Flores; Marc Ribó; José Alvarez-Sabin; Arantxa Ortega-Aznar; Mercedes Unzeta; Joan Montaner
Journal:  Cerebrovasc Dis       Date:  2011-12-01       Impact factor: 2.762

5.  Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.

Authors:  Tony Valente; Alejandro Gella; Montse Solé; Núria Durany; Mercedes Unzeta
Journal:  J Neurosci Res       Date:  2012-06-20       Impact factor: 4.164

Review 6.  Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues.

Authors:  R Lewinsohn
Journal:  Braz J Med Biol Res       Date:  1984       Impact factor: 2.590

7.  Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.

Authors:  A Abella; S García-Vicente; N Viguerie; A Ros-Baró; M Camps; M Palacín; A Zorzano; L Marti
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

8.  Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.

Authors:  Z Mészáros; T Szombathy; L Raimondi; I Karádi; L Romics; K Magyar
Journal:  Metabolism       Date:  1999-01       Impact factor: 8.694

9.  Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

10.  Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin.

Authors:  F Boomsma; F H Derkx; A H van den Meiracker; A J Man in 't Veld; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1995-06       Impact factor: 6.124

View more
  3 in total

1.  Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Authors:  Christian Carpéné; Francisco Les; Mounia Hasnaoui; Simon Biron; Picard Marceau; Denis Richard; Jean Galitzky; Denis R Joanisse; Pascale Mauriège
Journal:  J Physiol Biochem       Date:  2016-10-21       Impact factor: 4.158

2.  Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.

Authors:  Christian Carpéné; Mathilde Bizou; Karine Tréguer; Mounia Hasnaoui; Sandra Grès
Journal:  J Physiol Biochem       Date:  2015-01-09       Impact factor: 4.158

3.  Development of a HPLC-FL method to determine benzaldehyde after derivatization with N-acetylhydrazine acridone and its application for determination of semicarbazide-sensitive amine oxidase activity in human serum.

Authors:  Xiuli Dong; Jiayuan Tang; Yan Ren; Xiangming Chen
Journal:  RSC Adv       Date:  2019-02-26       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.